Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-07-23

Clinical Trial Update: Phase 2 Study of OPA-15406 Ointment in Pediatric Patients With Atopic Dermatitis [Phase 2]

View source ↗

Summary

Phase 2 study of OPA-15406 ointment in pediatric patients with atopic dermatitis completed; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • OPA-15406

Snippet

Sponsor: Otsuka Pharmaceutical Co., Ltd. | Conditions: Atopic Dermatitis | Phase 2 | Status: COMPLETED | Results posted: 2020-07-23